Calvenza-03 EIV/EHV Vaccine
(Flu/Rhino) BI

• CALVENZA®-03 EIV/EHV is an equine rhinopneumonitis and influenza, killed virus vaccine for healthy horses 6 months of age or older, including pregnant mares, against:

  • respiratory diseases due to equine herpesvirus types 1 and 4 (EHV-1 & EHV-4)

  • equine influenza virus (EIV) types A2 North American and A2 Eurasian

• The first equine influenza vaccine updated to follow OIE guidelines to contain Florida sublineage clade 1

Flexible administration - intramuscular and intranasal with a pliable nasal applicator

 

Features

• Incorporates Florida sublineage clade 1 (OH/03), Kentucky (KY/2/95), and Eurasian Newmarket/2/93 (NM/2/93) equine influenza strains

• Unique EHV-1 equine respiratory origin isolate

• Carbimmune® adjuvant formulation
   

Benefits

• Stimulates antibody production against EHV-1 & EHV-4

• Carbimmune® adjuvant system allows a dual-phase antigen presentation to deliver both rapid and long-lasting immunity

• Ultrafil® purification technology eliminates undesirable cellular components and extraneous protein to minimize the potential injection site reactions (such as heat, swelling, and inflammation)

• Flexible dose administration using intramuscular or intranasal techniques

• Pregnant mare may be safely vaccinated in any stage of gestation

• Can initiate vaccination in foals as early as 6 months of age

•  

• Ultrafil® purification technology

• Includes innovative pliable nasal applicator

• Safe for use in foals as young as 6 months of age

• Proven safe in pregnant mares